InforSense Limited Collaborates With GlaxoSmithKline (GSK) and Industry Innovators to Enable Virtual Drug Discovery  
10/15/2008 8:29:57 AM

LONDON and CAMBRIDGE, MA--(Marketwire - October 15, 2008) - InforSense Ltd., the leading provider of next generation business and scientific intelligence tools, today announced it has successfully completed a pilot project at world leading pharmaceutical company GlaxoSmithKline (GSK) to enable virtual drug discovery through virtual outsourcing of data analysis via secure Grid technology. The project is sponsored by SIMDAT -- a program funded by the European Commission under the Information Society Technologies Programme (IST) designed to test and enhance Grid data technology for product development and production process design.